TRAVERE THERAPEUTICS, INC. Earnings Per Share (Basic)
TRAVERE THERAPEUTICS, INC. (TVTX) reported Earnings Per Share (Basic) of -$0.37 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-04
- TRAVERE THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.37.
- TRAVERE THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.40.
- TRAVERE THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-12-31 was $0.03.
- TRAVERE THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was $0.29.
- TRAVERE THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$0.29.
- TRAVERE THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$4.08.
- TRAVERE THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$1.50.
- TRAVERE THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$4.37.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.37 10-Q · filed 2026-08-04 | -$0.78 10-Q · filed 2026-08-04 | -$0.75 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$0.48 derived: net income ÷ weighted average shares · filed 2026-08-04 | |||
| 2026-03-31 | -$0.40 10-Q · filed 2026-05-04 | -$0.38 derived: net income ÷ weighted average shares · filed 2026-05-04 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-05-04 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-08-04 | |||
| 2025-12-31 | $0.03 derived: net income ÷ weighted average shares · filed 2026-02-19 | $0.32 derived: net income ÷ weighted average shares · filed 2026-02-19 | $0.18 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$0.29 10-K · filed 2026-02-19 | |||
| 2025-09-30 | $0.29 10-Q · filed 2025-10-30 | $0.15 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$0.32 10-Q · filed 2025-10-30 | -$1.01 derived: net income ÷ weighted average shares · filed 2026-08-04 | |||
| 2025-06-30 | -$0.14 10-Q · filed 2026-08-04 | -$0.61 10-Q · filed 2026-08-04 | -$1.32 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$2.00 derived: net income ÷ weighted average shares · filed 2026-08-04 | |||
| 2025-03-31 | -$0.47 10-Q · filed 2026-05-04 | -$1.18 derived: net income ÷ weighted average shares · filed 2026-05-04 | -$1.88 derived: net income ÷ weighted average shares · filed 2026-05-04 | -$2.78 derived: net income ÷ weighted average shares · filed 2026-05-04 | |||
| 2024-12-31 | -$0.72 derived: net income ÷ weighted average shares · filed 2026-02-19 | -$1.43 derived: net income ÷ weighted average shares · filed 2026-02-19 | -$2.33 derived: net income ÷ weighted average shares · filed 2026-02-19 | -$4.08 10-K · filed 2026-02-19 | |||
| 2024-09-30 | -$0.70 10-Q · filed 2025-10-30 | -$1.61 derived: net income ÷ weighted average shares · filed 2025-10-30 | -$3.37 10-Q · filed 2025-10-30 | -$4.55 derived: net income ÷ weighted average shares · filed 2026-02-19 | |||
| 2024-06-30 | -$0.91 10-Q · filed 2025-08-06 | -$2.67 10-Q · filed 2025-08-06 | -$3.85 derived: net income ÷ weighted average shares · filed 2026-02-19 | -$1.90 derived: net income ÷ weighted average shares · filed 2026-02-19 | |||
| 2024-03-31 | -$1.76 10-Q · filed 2025-05-01 | -$2.95 derived: net income ÷ weighted average shares · filed 2026-02-19 | -$0.99 derived: net income ÷ weighted average shares · filed 2026-02-19 | -$2.11 derived: net income ÷ weighted average shares · filed 2026-02-19 | |||
| 2023-12-31 | -$1.18 10-K · filed 2024-02-20 | $0.79 derived: net income ÷ weighted average shares · filed 2026-02-19 | -$0.33 derived: net income ÷ weighted average shares · filed 2026-02-19 | -$1.50 10-K · filed 2026-02-19 | |||
| 2023-09-30 | $1.97 10-Q · filed 2024-10-31 | $0.85 derived: net income ÷ weighted average shares · filed 2024-10-31 | -$0.29 10-Q · filed 2024-10-31 | -$1.22 derived: net income ÷ weighted average shares · filed 2025-02-21 | |||
| 2023-06-30 | -$1.13 10-Q · filed 2024-08-01 | -$2.38 10-Q · filed 2024-08-01 | -$3.42 derived: net income ÷ weighted average shares · filed 2025-02-21 | -$4.51 derived: net income ÷ weighted average shares · filed 2025-02-21 | |||
| 2023-03-31 | -$1.27 10-Q · filed 2024-05-06 | -$2.30 derived: net income ÷ weighted average shares · filed 2025-02-21 | -$3.39 derived: net income ÷ weighted average shares · filed 2025-02-21 | -$4.44 derived: net income ÷ weighted average shares · filed 2025-02-21 | |||
| 2022-12-31 | -$1.03 10-K · filed 2024-02-20 | -$2.11 derived: net income ÷ weighted average shares · filed 2025-02-21 | -$3.17 derived: net income ÷ weighted average shares · filed 2025-02-21 | -$4.37 10-K · filed 2025-02-21 | |||
| 2022-09-30 | -$1.09 10-K · filed 2024-02-20 | -$2.14 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$3.34 10-Q · filed 2023-11-07 | -$4.19 derived: net income ÷ weighted average shares · filed 2024-02-20 | |||
| 2022-06-30 | -$1.05 10-K · filed 2024-02-20 | -$2.26 10-Q · filed 2023-08-03 | -$3.10 derived: net income ÷ weighted average shares · filed 2024-02-20 | -$3.70 derived: net income ÷ weighted average shares · filed 2024-02-20 | |||
| 2022-03-31 | -$1.20 10-K · filed 2024-02-20 | -$2.04 derived: net income ÷ weighted average shares · filed 2024-02-20 | -$2.64 derived: net income ÷ weighted average shares · filed 2024-02-20 | -$3.29 derived: net income ÷ weighted average shares · filed 2024-02-20 | |||
| 2021-12-31 | -$0.84 derived: net income ÷ weighted average shares · filed 2024-02-20 | -$1.42 derived: net income ÷ weighted average shares · filed 2024-02-20 | -$2.07 derived: net income ÷ weighted average shares · filed 2024-02-20 | -$3.01 10-K · filed 2024-02-20 | |||
| 2021-09-30 | -$0.59 10-Q · filed 2022-10-27 | -$1.23 derived: net income ÷ weighted average shares · filed 2022-10-27 | -$2.17 10-Q · filed 2022-10-27 | ||||
| 2021-06-30 | -$0.64 10-Q · filed 2022-08-04 | -$1.59 10-Q · filed 2022-08-04 | |||||
| 2021-03-31 | -$0.96 10-Q · filed 2022-05-05 | ||||||
| 2020-12-31 | -$3.56 10-K · filed 2023-02-23 | ||||||
| 2020-09-30 | -$0.44 10-Q · filed 2021-10-29 | -$1.03 10-Q · filed 2021-10-29 | |||||
| 2020-06-30 | -$0.58 10-Q · filed 2021-07-29 | -$0.57 10-Q · filed 2021-07-29 | |||||
| 2020-03-31 | $0.02 10-Q · filed 2021-05-06 | ||||||
| 2019-12-31 | -$3.46 10-K · filed 2022-02-24 | ||||||
| 2019-03-31 | -$0.99 10-Q · filed 2020-05-11 | ||||||
| 2018-12-31 | -$0.18 10-K · filed 2019-02-26 | -$2.54 10-K · filed 2019-02-26 | |||||
| 2018-09-30 | -$1.34 10-K · filed 2019-02-26 | ||||||
| 2018-06-30 | -$0.56 10-K · filed 2019-02-26 | ||||||
| 2018-03-31 | -$0.46 10-K · filed 2019-02-26 | ||||||
| 2017-12-31 | -$0.45 10-K · filed 2019-02-26 | -$1.54 10-K · filed 2019-02-26 | |||||
| 2017-09-30 | -$0.46 10-K · filed 2019-02-26 | -$1.10 10-Q · filed 2017-11-07 | |||||
| 2017-06-30 | -$0.34 10-K · filed 2019-02-26 | -$0.63 10-Q · filed 2017-08-09 | |||||
| 2017-03-31 | -$0.29 10-K · filed 2019-02-26 | ||||||
| 2016-12-31 | -$0.23 10-K · filed 2018-07-06 | -$1.29 10-K · filed 2019-02-26 | |||||
| 2016-09-30 | -$1.00 10-K · filed 2018-07-06 | -$1.07 10-Q · filed 2017-11-07 | |||||
| 2016-06-30 | -$0.37 10-K · filed 2018-07-06 | -$0.06 10-Q · filed 2017-08-09 | |||||
| 2016-03-31 | $0.31 10-K · filed 2018-07-06 | ||||||
| 2015-12-31 | -$0.07 10-K · filed 2017-03-01 | $3.49 10-K · filed 2018-07-06 | |||||
| 2015-09-30 | $2.95 10-K · filed 2017-03-01 | $3.67 10-Q · filed 2016-11-04 | |||||
| 2015-06-30 | -$0.73 10-K · filed 2017-03-01 | $0.45 10-Q · filed 2016-08-05 | |||||
| 2015-03-31 | $1.46 10-K · filed 2017-03-01 | ||||||
| 2014-12-31 | -$1.10 10-K · filed 2015-03-11 | -$4.43 10-K · filed 2017-03-01 | |||||
| 2014-09-30 | -$0.67 10-K · filed 2016-02-26 | -$0.73 10-Q · filed 2014-11-13 | -$3.25 10-Q · filed 2015-11-06 | -$3.24 10-Q · filed 2014-11-13 | |||
| 2014-06-30 | $0.46 10-K · filed 2016-02-26 | $0.33 10-Q · filed 2014-08-14 | -$2.61 10-Q · filed 2015-08-10 | -$2.54 10-Q · filed 2014-08-14 | |||
| 2014-03-31 | -$3.25 10-K · filed 2016-02-26 | ||||||
| 2013-12-31 | -$2.44 10-K · filed 2016-02-26 | ||||||
| 2013-09-30 | -$0.71 10-Q · filed 2014-11-13 | -$1.62 10-Q · filed 2014-11-13 | |||||
| 2013-06-30 | -$0.41 10-Q · filed 2014-08-14 | -$0.85 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |